Activity record

PGDB_A014249

Assay: viabilityTarget: IKZF3QC: standardized
Activity overview

inhibition = 80-100 %

TargetIKZF3
Cell lineRPMI-8226
Concentration500 nM
Time96 h
Assay / Readout% Inhibition / viability
Assay IDPGDB_AS001812
PatentWO2025162225A1
QC statusstandardized
Evidence details

Compound, assay context, and source

Compound

2D structure for PGDB_C024194
Compound IDPGDB_C024194
CompoundGT-06444
Source record IDPGDB_C024194
InChIKeyBLHXRBWUAVXRMT-UHFFFAOYSA-N

Assay context

Assay IDPGDB_AS001812
Assay familyviability
Assay systemcell_based
Readout% Inhibition
Concentration500 nM
Treatment time96 h
Detection target% Cell viability
TargetIKZF3
E3Not specified
Cell lineRPMI-8226
OrganismHomo sapiens

Source evidence

Patent IDWO2025162225A1
Compound location

GT-06444

GT-06444 enlarged structureGT-06444 location on patent page 27
Activity table
Page 157 · table single